Lipitor
Product Images NDC 21695-255

7 FDA label images from Rebel Distributors Corp · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Lipitor (NDC 21695-255). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rebel Distributors Corp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (A3c08a6d F986 4efc 9f96 3f0e652704dc 01)

Chemical Structure (A3c08a6d F986 4efc 9f96 3f0e652704dc 01)
Chemical structure diagram of the active ingredient in Lipitor, depicting the molecular arrangement including calcium ions (Ca2+) and water molecules (3H2O). The structure shows aromatic rings, fluorine substitution, and functional groups characteristic of atorvastatin calcium.*
FDA Label Image

Figure (A3c08a6d F986 4efc 9f96 3f0e652704dc 02)

Figure (A3c08a6d F986 4efc 9f96 3f0e652704dc 02)
A line graph comparing cumulative incidence percentages over approximately 3.5 years for two groups: Atorvastatin and Placebo. The x-axis represents time in years, while the y-axis shows cumulative incidence percentage. The graph includes a hazard ratio (HR=0.64) with confidence intervals and a p-value of 0.0005, indicating statistical analysis between the groups.*
FDA Label Image

Figure (A3c08a6d F986 4efc 9f96 3f0e652704dc 03)

Figure (A3c08a6d F986 4efc 9f96 3f0e652704dc 03)
A line graph comparing the cumulative hazard percentage over time for Atorvastatin and placebo groups. The x-axis represents time to first primary endpoint through four years of follow-up, and the y-axis shows cumulative hazard percentage. The Atorvastatin group shows a consistently lower hazard than placebo, with a hazard ratio of 0.63 (95% CI 0.48 to 0.83) and a p-value of 0.001.*
FDA Label Image

Figure (A3c08a6d F986 4efc 9f96 3f0e652704dc 04)

Figure (A3c08a6d F986 4efc 9f96 3f0e652704dc 04)
A line graph showing the percentage of subjects experiencing a first major cardiovascular event over 5 years for Atorvastatin 10 mg and 80 mg. The x-axis represents time in years, and the y-axis represents the percentage of subjects experiencing the event. The graph includes a hazard ratio (HR) of 0.78 with confidence interval (0.69-0.89) and a P-value of 0.0002.*
FDA Label Image

Logo (A3c08a6d F986 4efc 9f96 3f0e652704dc 05)

FDA Label Image

Logo (A3c08a6d F986 4efc 9f96 3f0e652704dc 06)

FDA Label Image

Lipitor 40mg (A3c08a6d F986 4efc 9f96 3f0e652704dc 07)

Lipitor 40mg (A3c08a6d F986 4efc 9f96 3f0e652704dc 07)
Lipitor 40mg tablet blister card labeled with 90 tablets. The label indicates each tablet contains atorvastatin calcium equivalent to 40mg atorvastatin. Manufactured by Pfizer Ireland Pharmaceuticals and distributed by Physician Partner, Thousand Oaks, CA. Includes storage instructions and product identification details, with multiple peel sections showing the same information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.